Fiduciary Alliance’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$350K Sell
3,813
-387
-9% -$33.9K 0.02% 412
2026
Q1
$351K Sell
4,200
-3,466
-45% -$309K 0.02% 423
2025
Q4
$606K Sell
7,666
-1,288
-14% -$101K 0.04% 313
2025
Q3
$716K Sell
8,954
-36,005
-80% -$3.07M 0.05% 281
2025
Q2
$4.09M Sell
44,959
-3,951
-8% -$361K 0.3% 78
2025
Q1
$4.58M Buy
48,910
+4,181
+9% +$374K 0.45% 59
2024
Q4
$4.07M Buy
+44,729
New +$4.27M 0.41% 62
2023
Q3
Sell
-13
Closed -$969 295
2023
Q2
$969 Buy
+13
New +$1.01K ﹤0.01% 865
2023
Q1
Sell
-12
Closed -$979 271
2022
Q4
$979 Buy
+12
New +$900 ﹤0.01% 782

Other funds holding CL

Fiduciary Alliance's CL Position: Q2 2026 in Review

Fiduciary Alliance reduced its Colgate-Palmolive (CL) stake by 9.2% in Q2 2026, selling an estimated $33.9K and leaving 3,813 shares worth $350K. The position accounts for 0.02% of the portfolio, ranked #412.

Fiduciary Alliance first reported a position in CL in Q4 2022 and has held it in 9 quarters since. The position peaked at $4.58M in Q1 2025. 2,011 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Fiduciary Alliance held 3,813 shares of Colgate-Palmolive worth $350K as of Q2 2026.
  • Fiduciary Alliance sold 387 Colgate-Palmolive shares in Q2 2026, an estimated $33.9K.
  • Colgate-Palmolive made up 0.02% of Fiduciary Alliance's portfolio in Q2 2026, its #412 holding.
  • Fiduciary Alliance first reported a position in Colgate-Palmolive in Q4 2022 and has held it in 9 quarters since.
  • Fiduciary Alliance's Colgate-Palmolive position peaked at $4.58M in Q1 2025.
  • 2,011 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Fiduciary Alliance's 13F filing for Q2 2026, filed 20 Jul 2026.